For in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasal, nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19, Assay targets non-structural Polyprotein (pp1ab) of SARS-CoV-2 virus
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Emergency Use Authorization (EUA)
Included
High
No
Molecular Testing
Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q
Kit
NPA – 92/92 = 100% (95% CI: 95.99 to 100%)
2°C to 8°C
Yes
SARS-CoV-2
PPA – 92/92 = 100% (95% CI: 95.99 to 100%)
RT-PCR
Tests and controls
96 Tests/Kit
<75 min. after extraction